NEA Management Company, LLC - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, NEA Management Company, LLC held in its portfolio 27 assets valued at $1,961,136,508 (i.e. $1.96B).

The most valuable assets in the portfolio included: Celcuity Inc. ($352.64M), Rhythm Pharmaceuticals, Inc. ($311.48M), and Arcellx, Inc. ($198.55M).

The chart below shows the top 10 valuable assets, and the table below shows the top 27 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.
Data Source: SEC.
Top Valuable Stocks in NEA Management Company, LLC Portfolio
Celcuity Inc.
Rhythm Pharmaceuticals, Inc.
Arcellx, Inc.
Trevi Therapeutics, Inc.
Savara, Inc.
Zenas BioPharma, Inc.
Monte Rosa Therapeutics, Inc.
MBX Biosciences, Inc.
Coursera, Inc.
Aurinia Pharmaceuticals, Inc.
NEA Management Company, LLC - Stock Holdings in 13F Filings (SEC)
Items per page:
0 of 0
Name of Issuer No. of Shares Value ($) Class
Celcuity Inc. 3535561 352636854 COM
Rhythm Pharmaceuticals, Inc. 2909956 311481690 COM
Arcellx, Inc. 3045262 198551082 COMMON STOCK
Trevi Therapeutics, Inc. 13222228 165542295 COM
Savara, Inc. 24471264 147561722 COM
Zenas BioPharma, Inc. 3523219 127928082 COM
Monte Rosa Therapeutics, Inc. 7692298 120615233 COM
MBX Biosciences, Inc. 3614486 114000888 COM
Coursera, Inc. 12867769 94706780 COM
Aurinia Pharmaceuticals, Inc. 3969834 63318852 COM
Gossamer Bio, Inc. 18093034 56088405 COM
CRISPR Therapeutics AG 1058570 55511411 NAMEN AKT
ORIC Pharmaceuticals, Inc. 4118621 33690320 COM
Phathom Pharmaceauticals, Inc. 1960169 32519204 COM
CVRx, Inc. 2026083 14385189 COM
X4 Pharmaceuticals, Inc. 3233743 12934972 COM
Champions Oncology, Inc. 1713720 11841805 COM NEW
Black Diamond Therapeutics, Inc. 4448757 10810480 COM
Korro Bio, Inc. 1090793 8737252 COM
Inventiva SA 1462586 6801025 ADS
Nkarta, Inc. 3568781 6602245 COM
Senti Biosciences, Inc. 3775615 3926640 COM NEW
LeonaBio, Inc. 464398 3515493 COM
Synlogic, Inc. 2922772 3273505 COM NEW
Marker Therapeutics, Inc. 1625678 2422260 COM NEW
OnKure Therapeutics, Inc. 478548 1387789 COM CL A
ImageneBio, Inc. 50005 345035 COM